Pfizer (PFE) Asset Utilization Ratio (2009 - 2026)

Pfizer has disclosed Asset Utilization Ratio across 18 years of filings, most recently posting 0.12 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 19.34% year-over-year to 0.12; the TTM figure through Mar 2026 stood at 0.12 (down 19.34% YoY), while the FY2025 annual figure was 0.3, up 666.08% from the prior year.
• Asset Utilization Ratio improved to 0.12 in Q1 2026, from 0.12 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for PFE reached as high as 0.67 in Q4 2022 and fell as low as 0.03 in Q3 2025.
• The 5-year median for Asset Utilization Ratio is 0.15 (2024), against an average of 0.23.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio slumped 91.78% — and 2024, when it soared 166.17%.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.67 in 2022, then slumped by 91.7% to 0.06 in 2023, then soared by 166.21% to 0.15 in 2024, then declined by 20.98% to 0.12 in 2025, then climbed by 1.17% to 0.12 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.12, 0.12, and 0.03 for Q1 2026, Q4 2025, and Q3 2025 respectively.